$18.47+0.69|(+3.88%)
52W H: 20.049952W L: 7.07Beta: 1.89

About Neogenomics Inc

Frequently Asked Questions

What is the 52-week range for NEO?

The 52-week high is $20.0499 and the 52-week low is $7.07.

What is the P/E ratio for NEO?

The P/E ratio data is currently unavailable.

What is the dividend yield for NEO?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -6.31%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -6.77%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 1.82.

Analyst Recommendation Trends

Wall Street analyst consensus for NEO over the last few months:

2026-09-01
Buy: 7
S.Buy: 4
Hold: 5
Sell: 0
2026-08-01
Buy: 7
S.Buy: 4
Hold: 5
Sell: 0
2026-07-01
Buy: 7
S.Buy: 4
Hold: 5
Sell: 0
2026-06-01
Buy: 7
S.Buy: 4
Hold: 5
Sell: 0

Latest NEO News

Why Women-Run Companies Deserve a Place in Your Portfolio

BMY, HALO, TGT, NEO and ROST stocks show how women-led companies are redefining growth with discipline, agility and results.

Yahoo9/24/2026

3 Healthcare Stocks We’re Skeptical Of

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 38.9% gain over the past six months, beating the S&P 500 by 20.9 percentage points.

Yahoo9/23/2026

3 Reasons NEO is Risky and 1 Stock to Buy Instead

What a time it’s been for NeoGenomics. In the past six months alone, the company’s stock price has increased by a massive 138%, reaching $19.30 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Yahoo9/22/2026

NeoGenomics (NEO) Expands Precision Oncology Focus, Is The Stock Fairly Valued?

NeoGenomics stock reaction to precision oncology expansion plan NeoGenomics (NEO) drew investor attention after executives detailed plans to expand in community-based precision oncology, highlighting next-generation sequencing, minimal residual disease testing, and workflow tools for community physicians as key focus areas. NeoGenomics shares have been on a strong run recently, with a 30-day share price return of 14.31% and a 90-day gain of 69.22%. The 1-year total shareholder return of...

Yahoo9/22/2026

Is NeoGenomics’ (NEO) Community NGS Push Quietly Redefining Its Core Earnings Engine?

Earlier in 2026, NeoGenomics executives detailed plans to expand in community-based precision oncology, with a particular push into next-generation sequencing, minimal residual disease testing, and workflow tools for community oncologists. An important takeaway is that NGS already represents a relatively small share of test volume but a much larger portion of clinical revenue, underscoring how mix shift toward advanced assays could reshape the company’s earnings profile. We’ll now examine...

Yahoo9/21/2026

NeoGenomics Highlights NGS, MRD Growth Strategy at Morgan Stanley Conference

NeoGenomics (NASDAQ:NEO) executives outlined the company’s strategy to expand its role in community-based precision oncology, emphasizing growth in next-generation sequencing, minimal residual disease testing and workflow tools designed for physicians treating patients closer to home. Speaking at t

Yahoo9/21/2026

1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

Yahoo9/18/2026

Novavax (NVAX) Soars 7.0%: Is Further Upside Left in the Stock?

Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Yahoo9/18/2026

NeoGenomics, Inc. (NEO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

NeoGenomics, Inc. (NEO) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 7:45 AM EDTCompany ParticipantsAnthony Zook - CEO &...

SeekingAlpha9/15/2026

A Look Back at Testing & Diagnostics Services Stocks’ Q2 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at NeoGenomics (NASDAQ:NEO) and its peers.

Yahoo9/11/2026

3 Promising Genomics Stocks in the Spotlight in 2026

Genomics is reshaping healthcare, with WGS, NEO and NTLA advancing diagnostics and precision medicine.

Yahoo9/8/2026

Anortech Receives US$1.0 Million Cash and Shares from Sarfartoq Ree Project Transaction

VANCOUVER, British Columbia, Sept. 03, 2026 (GLOBE NEWSWIRE) -- AnorTech Inc. (“AnorTech” or the “Company”) (TSX Venture Exchange “ANOR”; OTCQB “ANORF”) is pleased to announce that, the Company has received cash and shares following the closing of Greenland Mines Ltd.’s acquisition of the Sarfartoq rare earth element (“REE”) project in Greenland from Neo Performance Materials Inc. Under the terms of AnorTech’s agreement with Neo (see NR2026-02), the Company was entitled to receive 5% of the tota

Yahoo9/3/2026

How Neo’s New Rare Earth Supply Pact Could Reshape Neo Performance Materials’ (TSX:NEO) Magnet Ambitions

Neo Performance Materials announced that it entered into a binding term sheet with France’s Carester SAS to secure heavy rare earth supply, expand recycling of magnet scrap, and toll-process mixed rare earth carbonate in Europe, supporting its upcoming European sintered magnet facility that is planned to start commercial production in the second half of 2026. This partnership effectively tightens Neo’s European rare earth magnetics loop by combining secure heavy rare earth inputs,...

Yahoo9/3/2026

Related Stocks (Peers)

Companies operating in similar sectors to NEO:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-01Olivo Alicia C-2,692--
2026-08-21Stone Warren-28,106--
2026-08-21Stone Warren-11,060--
2026-08-21Stone Warren+28,106--
2026-08-04Aunan Greg D-20,000$16.07$321,400
2026-06-23Starrett Carolyn S+14,125--
2026-06-23Starrett Carolyn S+9,784--
2026-06-15TETRAULT LYNN A.-5,307$11.1$58,908
2026-06-09TETRAULT LYNN A.-5,307$11.29$59,916
2026-06-01Kenny John P.+15,970--
2026-06-01Kenny John P.+11,069--
2026-06-01Kenny John P.-5,893--
2026-06-01Kenny John P.+5,893--
2026-06-01Williams Felicia+15,970--
2026-06-01Williams Felicia+11,069--
2026-06-01Williams Felicia-23,077--
2026-06-01Williams Felicia+23,077--
2026-06-01TETRAULT LYNN A.+15,970--
2026-06-01TETRAULT LYNN A.+11,069--
2026-06-01TETRAULT LYNN A.-23,077--
2026-06-01TETRAULT LYNN A.+23,077--
2026-06-01Perez David Brian+15,970--
2026-06-01Perez David Brian+11,069--
2026-06-01Perez David Brian-23,077--
2026-06-01Perez David Brian+23,077--
2026-06-01Kelly Michael Aaron+15,970--
2026-06-01Kelly Michael Aaron+11,069--
2026-06-01Kelly Michael Aaron-23,077--
2026-06-01Kelly Michael Aaron+23,077--
2026-06-01KANOVSKY STEPHEN M+15,970--
2026-06-01KANOVSKY STEPHEN M+11,069--
2026-06-01KANOVSKY STEPHEN M-23,077--
2026-06-01KANOVSKY STEPHEN M+23,077--
2026-06-01Gunn Neil+15,970--
2026-06-01Gunn Neil+11,069--
2026-06-01Gunn Neil-23,077--
2026-06-01Gunn Neil+23,077--
2026-06-01Green Marjorie C+15,970--
2026-06-01Green Marjorie C+11,069--
2026-06-01Green Marjorie C-22,964--
2026-06-01Green Marjorie C+22,964--
2026-05-11Olivo Alicia C-3,944--
2026-05-11Olivo Alicia C-2,559--
2026-05-11Olivo Alicia C+3,944--
2026-05-11Stone Warren-5,830--
2026-05-11Stone Warren-3,783--
2026-05-11Stone Warren+5,830--
2026-05-02Aunan Greg D-5,372--
2026-05-02Aunan Greg D-1,309--
2026-05-02Aunan Greg D+5,372--
2026-05-02Stone Warren-5,969--
2026-05-02Stone Warren-2,349--
2026-05-02Stone Warren+5,969--
2026-05-01Aunan Greg D-937--
2026-05-01Olivo Alicia C-1,042--
2026-04-01Stone Warren-17,562--
2026-04-01Stone Warren-6,911--
2026-04-01Stone Warren+17,562--
2026-04-01Zook Anthony P.-140,498--
2026-04-01Zook Anthony P.-45,453--
2026-04-01Zook Anthony P.+140,498--
2026-03-01Aunan Greg D+22,889--
2026-03-01Aunan Greg D+36,825--
2026-03-01Olivo Alicia C+89,013--
2026-03-01Olivo Alicia C+147,804--
2026-03-01Stone Warren+152,594--
2026-03-01Stone Warren+253,378--
2026-03-01Zook Anthony P.+406,918--
2026-03-01Zook Anthony P.+675,676--
2026-02-23Stone Warren-8,443--
2026-02-23Stone Warren-3,323--
2026-02-23Stone Warren+8,443--
2026-02-23Sherman Jeffrey Scott-15,535--
2026-02-23Sherman Jeffrey Scott-3,783--
2026-02-23Sherman Jeffrey Scott+15,535--
2026-02-23Olivo Alicia C-8,443--
2026-02-23Olivo Alicia C-3,323--
2026-02-23Olivo Alicia C+8,443--
2026-02-21Stone Warren-28,105--
2026-02-21Stone Warren-7,142--
2026-02-21Stone Warren+28,105--
2026-02-21Sherman Jeffrey Scott-42,158--
2026-02-21Sherman Jeffrey Scott-10,729--
2026-02-21Sherman Jeffrey Scott+42,158--
2026-02-21Olivo Alicia C-21,079--
2026-02-21Olivo Alicia C-8,295--
2026-02-21Olivo Alicia C+21,079--
2026-02-21Aunan Greg D-6,323--
2026-02-21Aunan Greg D-1,875--
2026-02-21Aunan Greg D+6,323--
2026-01-20Stone Warren-22,128$12.5037$276,682
2026-01-13Stone Warren-15,127--
2026-01-13Stone Warren+59,382--
2026-01-13Olivo Alicia C-15,145--
2026-01-13Olivo Alicia C+59,382--
2026-01-01Kenny John P.+5,893--
2026-01-01Kenny John P.+4,171--
2025-12-07Sherman Jeffrey Scott-11,938--
2025-12-01Stone Warren-8,776--
2025-11-25Olivo Alicia C-8,977--
2025-11-25Olivo Alicia C-20,916$12$250,992
2025-11-25Olivo Alicia C+8,977$10.05$90,219
2025-10-16Olivo Alicia C-4,918$10$49,180